Binding properties of chimeric insulin receptors containing the cysteine-rich domain of either the insulin-like growth factor I receptor or the insulin receptor related receptor
- PMID: 1645190
- DOI: 10.1021/bi00235a001
Binding properties of chimeric insulin receptors containing the cysteine-rich domain of either the insulin-like growth factor I receptor or the insulin receptor related receptor
Abstract
We constructed and expressed chimeric receptor cDNAs with insulin receptor exon 3 (residues 191-297 of the cysteine-rich region) replaced with either the comparable region of the insulin-like growth factor I receptor (IGF-IR) or the insulin receptor related receptor (IRR). Both chimeric receptors still could bind insulin with as high affinity as the wild-type receptor. In addition, chimeric receptors containing exon 3 of the IGF-IR could also bind with high affinity both IGF-I and IGF-II. In contrast, chimeric receptors containing exon 3 of IRR did not bind either IGF-I, IGF-II, or relaxin. These results indicate that (1) the high affinity of binding of insulin to its receptor can occur in the absence of insulin receptor specific residues encoded by exon 3, the cysteine-rich region; (2) the cysteine-rich region of the IGF-I receptor can confer high-affinity binding to both IGF-I and IGF-II; and 3) the IRR is unlikely to be a receptor for either IGF-I, IGF-II, or relaxin.
Similar articles
-
Delineation of the IGF-II C domain elements involved in binding and activation of the IR-A, IR-B and IGF-IR.Growth Horm IGF Res. 2015 Feb;25(1):20-7. doi: 10.1016/j.ghir.2014.09.004. Epub 2014 Oct 30. Growth Horm IGF Res. 2015. PMID: 25458127
-
The design, expression, and characterization of human insulin-like growth factor II (IGF-II) mutants specific for either the IGF-II/cation-independent mannose 6-phosphate receptor or IGF-I receptor.J Biol Chem. 1991 Nov 5;266(31):20626-35. J Biol Chem. 1991. PMID: 1657932
-
Altered affinity of insulin-like growth factor II (IGF-II) for receptors and IGF-binding proteins, resulting from limited modifications of the IGF-II molecule.Biochem J. 1991 Aug 15;278 ( Pt 1)(Pt 1):249-54. doi: 10.1042/bj2780249. Biochem J. 1991. PMID: 1715685 Free PMC article.
-
Insulin-like growth factor (IGF)/somatomedin receptor subtypes: structure, function, and relationships to insulin receptors and IGF carrier proteins.Horm Res. 1986;24(2-3):152-9. doi: 10.1159/000180554. Horm Res. 1986. PMID: 2944811 Review.
-
The insulin-binding domain of insulin receptor is encoded by exon 2 and exon 3.J Cell Biochem. 1992 Jan;48(1):19-25. doi: 10.1002/jcb.240480105. J Cell Biochem. 1992. PMID: 1316357 Review.
Cited by
-
A region of the insulin receptor important for ligand binding (residues 450-601) is recognized by patients' autoimmune antibodies and inhibitory monoclonal antibodies.Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9858-62. doi: 10.1073/pnas.88.21.9858. Proc Natl Acad Sci U S A. 1991. PMID: 1719540 Free PMC article.
-
Something old, something new and something borrowed: emerging paradigm of insulin-like growth factor type 1 receptor (IGF-1R) signaling regulation.Cell Mol Life Sci. 2014 Jul;71(13):2403-27. doi: 10.1007/s00018-013-1514-y. Epub 2013 Nov 26. Cell Mol Life Sci. 2014. PMID: 24276851 Free PMC article. Review.
-
Articular cartilage destruction in experimental inflammatory arthritis: insulin-like growth factor-1 regulation of proteoglycan metabolism in chondrocytes.Histochem J. 1996 Dec;28(12):835-57. doi: 10.1007/BF02331388. Histochem J. 1996. PMID: 9015706 Review.
-
Theoretical and computational studies of peptides and receptors of the insulin family.Membranes (Basel). 2015 Feb 11;5(1):48-83. doi: 10.3390/membranes5010048. Membranes (Basel). 2015. PMID: 25680077 Free PMC article. Review.
-
High affinity binding sites for proinsulin in human IM-9 lymphoblasts.Diabetologia. 1996 Apr;39(4):421-32. doi: 10.1007/BF00400673. Diabetologia. 1996. PMID: 8777991
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical